• Medientyp: E-Artikel
  • Titel: Topical oro-dispersible budesonide tablets for stricture prevention after near circumferential ESD for esophageal squamous cell cancer – a case report
  • Beteiligte: Mathies, Daniel; Oyama, Tsuneo; Steinbrück, Ingo; Dumoulin, Franz Ludwig
  • Erschienen: Georg Thieme Verlag KG, 2021
  • Erschienen in: Zeitschrift für Gastroenterologie
  • Sprache: Deutsch
  • DOI: 10.1055/a-1409-1076
  • ISSN: 0044-2771; 1439-7803
  • Schlagwörter: Gastroenterology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:p> Background Endoscopic resection is the treatment of choice for early esophageal cancers. However, resections comprising more than 70–80 % of the circumference are associated with a high risk of stricture formation. Currently, repetitive local injections and/or systemic steroids are given for prevention.</jats:p><jats:p> Case report We present here the case of a 78-year-old male patient who had a near circumferential endoscopic submucosal dissection for a pT1a mm, L0, V0, R0, G2 esophageal squamous cell cancer. At the end of endoscopic resection, 80 mg of triamcinolone was injected locally. The patient was then treated with oro-dispersible budesonide tablets (2 × 1 mg/day) and nystatin (4 × 100 000 I.E.) for 8 weeks. This treatment resulted in complete healing without any stricture formation and did not result in any complications.</jats:p><jats:p> Discussion Treatment with orodispersible budesonide tablets could help prevent strictures after large endoscopic resections in the esophagus.</jats:p>